Clinical trial Recruiting at 1 site Interventional Ages 7 to 12

AmblyoFix for one-eye (unilateral) amblyopia in children 7–12 years

Official title: Prospective Clinical Trial Evaluating AmblyoFix for the Treatment of Unilateral Amblyopia in Children

Run by Eyesight Electronics · NCT07323953 · Data updated 2026-11-12

This will test whether AmblyoFix, an at-home binocular digital therapy, can improve the weaker eye's vision in children aged 7–12 with unilateral amblyopia compared with past patching treatment.

More Amblyopia trials

Quick facts

Study typeInterventional
Ages7 Years to 12 Years
SexAll
Enrollment33 (estimated)
SponsorEyesight Electronics
Industry-sponsored
Locations1 site (Cairo)
StatusRecruiting
StartedMarch 16, 2026
Main results expectedFebruary 25, 2027
Study endsMarch 16, 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT07323953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 7–12 with unilateral amblyopia, amblyopic-eye BCVA between 0.3 and 1.3 logMAR, an interocular difference of ≥0.2 logMAR, stable refractive correction, and access to a laptop with internet are the ideal candidates.

Probably not a fit

Children with prior amblyopia treatment beyond refractive adaptation, severe ocular pathology or high myopia, significant cognitive/developmental delay, a history of light-induced seizures, or no suitable home computer/internet are unlikely to benefit or qualify.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm, non-inferiority trial testing AmblyoFix binocular digital therapy delivered at home and comparing outcomes to a retrospective cohort previously treated with patching. Thirty-three children aged 7–12 with unilateral amblyopia and specified visual acuity and refractive stability will be enrolled to allow for at least 28 completers at Week 24. The primary outcome is change in amblyopic-eye best-corrected visual acuity (logMAR) from baseline to Week 24 measured under standardized Snellen or ETDRS protocols by certified, masked outcome assessors. Therapy adherence, safety, and vision outcomes will be monitored with digital logging and clinic visits.

Why it matters

Potential benefit: If successful, AmblyoFix could provide an effective at-home alternative to patching that improves vision in the amblyopic eye for older children.

How similar studies have gone: Previous trials of binocular digital therapies for amblyopia have shown mixed but promising results—some matched patching while others did not—so the approach has partial supporting evidence but is not yet definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 7-12 years.
* Unilateral amblyopia secondary to anisometropia and/or mild strabismus.
* BCVA in amblyopic eye between 20/40-20/400 (0.3-1.3 logMAR); fellow eye ≥20/32 (≤0.2 logMAR).
* Interocular difference ≥2 lines (≥0.2 logMAR).
* Stable refractive correction for ≥16 weeks or \<0.1 logMAR change across two visits ≥8 weeks apart.
* Cycloplegic refraction within 7 months meeting anisometropia criteria (e.g., hyperopia ≥+2.50 D).
* Access to a suitable home environment (laptop and internet).
* Parent/guardian consent and child assent (7+ year olds).

Exclusion Criteria:

* Atropine use within 2 weeks before starting treatment
* Prior amblyopia treatment beyond refractive adaptation.
* Myopia \>-6.00 D SE, previous ocular surgery, or other ocular pathology.
* Severe cognitive/developmental delay impeding compliance.
* History of light-induced seizures.
* Inability/unwillingness to comply with digital monitoring.
* Any condition compromising safety or trial integrity.

Where it's running

  • Watany Research and Development Center, Watany Eye Hospital
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.